We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Regulatory News: GeNeuro (Euronext Paris : CH0308403085 – GNRO), société biopharmaceutique développant de nouveaux traitements pour les maladies neurodégénératives et auto-immunes, annonce que...
Regulatory News: GeNeuro (Euronext Paris: CH0308403085 - GNRO), a biopharmaceutical company focused on addressing the factors driving the progression of neurodegenerative and autoimmune...
Regulatory News: GeNeuro (Euronext Paris : CH0308403085 – GNRO), société biopharmaceutique développant de nouveaux traitements pour les maladies neurodégénératives et auto-immunes, telles que la...
Regulatory News: La société GENEURO (Paris:GNRO) et la société GILBERT DUPONT ont mis fin au contrat de liquidité conclu le 06 mars 2021. Cette résiliation a pris effet le 30 juin 2024 au soir. A...
Market: Euronext Paris ISIN code / Mnemo: CH0308403085 / GNRO Web site: www.geneuro.com Regulatory News: Pursuant to the liquidity contract entrusted by GENEURO SA (Paris:GNRO) to Gilbert Dupont...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.004 | 5.49450549451 | 0.0728 | 0.0768 | 0.0612 | 21238 | 0.0683473 | DE |
4 | -0.0032 | -4 | 0.08 | 0.0848 | 0.06 | 25568 | 0.07218609 | DE |
12 | 0.0068 | 9.71428571429 | 0.07 | 0.1 | 0.06 | 34400 | 0.0746085 | DE |
26 | -1.7082 | -95.6974789916 | 1.785 | 2.35 | 0.0558 | 66281 | 0.21036453 | DE |
52 | -0.9832 | -92.7547169811 | 1.06 | 2.35 | 0.0558 | 38146 | 0.32710695 | DE |
156 | -3.5632 | -97.8901098901 | 3.64 | 4.24 | 0.0558 | 16294 | 0.79687163 | DE |
260 | -3.3832 | -97.7803468208 | 3.46 | 6.28 | 0.0558 | 12628 | 1.43491766 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions